Abstract:Background Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multiple groups of CSC-positive HCCs. We thus aimed to investigate essential metabolic features of hepatic CSCs via using HCCs with miR-192-5p silencing as a model. Methods Datasets from two independent HCC cohorts were used. Data integration analyses of miR-192-5p with metabolome and mRNA transcriptome data in HCC Cohort 1 were performed to investigate miR-192-5p related metabolic features, which was further validated in Cohort 2. Cellular and molecular assays were performed to examine whether and how miR-192-5p regulated the identified metabolic features. Co-culture systems consisting of HCC cells and LX2 (human hepatic stellate cell line) or THP1 (human monocyte cell line) were established to explore effects of the identified metabolic properties on stemness features of HCC cells via interacting with co-cultured non-tumor cells. Results High levels of glycolysis-related metabolites and genes were present in HCCs with low miR-192-5p and CSC-positive HCCs in two independent HCC cohorts. miR-192-5p knockout cells displayed CSC features and miR-192-5p loss led to an enhanced glycolytic phenotype via upregulating three bona fide targets, GLUT1 and PFKFB3 (two glycolytic enzymes) and c-Myc (regulating glycolytic genes’ expression). Meanwhile, c-Myc suppressed miR-192-5p transcription, ensuring a low-miR-192-5p/high-c-Myc loop to maintain hyperglycolysis. Moreover, over-produced lactic acid from hyperglycolytic HCC cells stimulated the ERK phosphorylation of co-cultured LX2 and THP1 non-tumor cells partially via NDRG3 and MCT1, which in turn promoted cell malignancy and stemness of HCC cells. Consistently, HCC patients with low level of miR-192-5p in their tumor tissues and high level of NDRG3 or MCT1 in their non-tumor tissues had the shortest overall survival. Conclusions In CSC-positive HCCs, miR-192-5p loss enhanced glycolysis and over produced lactate might further increase HCC malignant features via interacting with environmental non-tumor cells.

HSF1 Promotes the Inhibition of EMT-associated Migration by Low Glucose Via Directly Regulating Snail1 Expression in HCC Cells.

Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells under Hypoxic and Low-Glucose Conditions

Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment

Loss of MiR-192-5p Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma.

Hypoxia Induces Epithelial-Mesenchymal Transition Via Activation of SNAI1 by Hypoxia-Inducible Factor -1Α in Hepatocellular Carcinoma.

HIF-1α Induces the Epithelial-Mesenchymal Transition in Gastric Cancer Stem Cells Through the Snail Pathway.

HSF1: a Mediator in Metabolic Alteration of Hepatocellular Carcinoma Cells in Cross-Talking with Tumor-Associated Macrophages.

AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment

EGFR Mediates Epithelial‑mesenchymal Transition Through the Akt/GSK-3β/Snail Signaling Pathway to Promote Liver Cancer Proliferation and Migration.

Effects of GLS1 on the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma in Vitro and in Vivo

Regulatory Role of Hexosamine Biosynthetic Pathway on Hepatic Cancer Stem Cell Marker CD133 under Low Glucose Conditions

STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma

Targeting Src SH3 domain-mediated glycolysis of hepatic stellate cells suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis

Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions

Glucose Regulates Heat Shock Factor 1 Transcription Activity Via Mtor Pathway in HCC Cell Lines.

Long Noncoding RNA SLC2A1‐AS1 Regulates Aerobic Glycolysis and Progression in Hepatocellular Carcinoma Via Inhibiting the STAT3/FOXM1/GLUT1 Pathway

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway

Downregulated Connexin32 Promotes EMT Through the Wnt/β-catenin Pathway by Targeting Snail Expression in Hepatocellular Carcinoma

Restoration of FBP1 Suppressed Snail-induced Epithelial to Mesenchymal Transition in Hepatocellular Carcinoma

LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis Through FUS Recruitment and SLC10A1 Modulation

Hypoxia Promotes Migration/invasion and Glycolysis in Head and Neck Squamous Cell Carcinoma Via an HIF-1α-MTDH Loop.